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Abstract  
 
Gene therapy is an expanding field and it can treat genetic and acquired diseases.  
It was found that formulations with DNA: CM-β–CD (Carboxymethyl-beta-cyclodextrin): 
Pluronic-F127 1:3:3 and 1:3 DNA: CM-β–CD are the most stable formulations indicating 
high incorporation of DNA within CM-β –CD. Gel electrophoresis revealed DNA with low 
CM-β –CD concentration has formed a more stable complex. Samples 1:3 DNA: CM-β–CD 
and 1:3:3 DNA: CM-β–CD: Pluronic-127 show no DNA fragment suggesting good 
condensation of DNA inside cyclodextrin cavity. This was confirmed by fluorescence data 
where fluorescence intensity was reduced for samples DNA: CM-β–CD 1:3. Overall the 
findings showed that Carboxymethyl-beta-cyclodextrin (as a novel non-viral gene vector) 
was able to provide condensation and protection to the DNA, with and without Pluronic-
F127, at low concentration. pDNA/CM-β–CD complex has not just shown to be able to 
transfect COS 7 and SH-SY5Y cell lines but it gave a higher transfection efficiency than that 
produced by the  TransIT-LT1 commercial transfection reagent.  
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1. Introduction  
 
Gene therapy is the insertion of functioning genes into cells to correct cellular dysfunction or 
to provide new cellular functions (Mulligan et al, 1993). The concept of gene therapy emerged 
in the early 1960s when genetically marked cell transformation by papovaviruses polyoma and 
SV40 were identified (Hill et al, 1999). Over the past years there has been a remarkable 
expansion in gene therapy fields, which capture the interest of many researchers and much 
progress has been made. Many clinical trials have been conducted with highly promising 
results (Silva et al, 2011;  Akinori et al, 2009), making gene therapy the medicine of future 
that could significantly contribute to the development of new treatment to cure both genetic 
and acquired conditions. In clinic, gene therapy has not been globally successful because of the 
inefficient delivery of genetic material to their correct intracellular sites and the poor 
toxicological profile of some vectors. For gene therapy success, gene must inter the target cell 
without any biodegradation or immune response (Liu and Huang, 2002).   
 
 
Currently several methods have been used to deliver a gene into the nucleus of a cell in a 
process known as transfection. The first method is direct injection of DNA into cell nucleus 
using mechanical, ultrasonic, electric, hydrodynamic or laser-based energy, creating temporary 
weak points in the membrane of the target cell and allows the DNA to inter the cell by diffusion 
(Liu et al, 2002). This direct approach is considered a safe and effective method but is limited 
to specific applications that involve easily accessible and discrete targets (Howden, 2008). The 
second method involves the use of gene carriers, which can be either viral or nor-viral vectors. 
The viral vector has been the most utilized and most successful agent in the gene delivery 
because of their high transfection efficiency in vivo, but their high immunogenicity, high cost 
and limited size carrier, has led scientists to find alternative method (Hoag et al, 2005). 
Consequently non-viral vectors have been designed; these vectors are relatively inexpensive, 
show no signs of oncogenicity and have lower immune response. However low transfection 
efficiency has been reported due to differences in barrier permeation between the target cell 
nucleus and extracellular space (Cryan et al, 2004). Thus, the main points that should be taken 
into account for developing non-viral vectors are the introduction of the gene into the cell and 
increasing transfection efficiency.  
 
 
Despite their relatively low efficiency, non-viral approaches are considered safer and 
preferable methods in gene delivery. Several different types of non-viral vectors have been 
investigated for gene therapy applications this includes: polymers, lipids/liposomes, 
dendrimers and cell penetrating peptides.  The main function of these vectors is to deliver the 
therapeutic gene to the target cell to correct the defective or mutated gene. Non-viral vectors 
are generally used to transfer different types of nucleic acid including RNA, small and large 
DNA molecules (Hoag et al, 2005). Many barriers prevent the DNA from reaching their target 
and performing their function. After loading the genetic material to the vector, the vector must 
be delivered to the blood vessels and must be stable to avoid clearance by albumin as a result 
of their high surface charge. Next, the vector must pass through the epithelial tissues of blood 
vessels and enter the target cell through endocytosis process.            
Although choosing the most appropriate vectors is the most critical step in achieving gene 
therapy, none of the currently available non-viral vectors fulfills ideal vector properties (Liu et 
al, 2002). This has led to research focus on suitable ideal non-viral vector delivery system. 
Gene delivery systems have focused in chemical carriers (lipid based, polymer based and 
peptide based) as main non-viral vectors which have been designed to efficiently protect, 
transport and deliver the gene to target specific cells with minimum toxicity and high 
transfection rates.  
Cyclodextrin as a non-viral gene carrier, cyclodextrin and its unique chemical structure has 
become an area of interest especially in DNA delivery, where it shows a great ability in forming 
inclusion complexes with DNA. Cyclodextrin (CDs) are naturally occurring cyclic 
oligosaccharides consist of (α-1,4)-linked α-D-glucopyranose units and contain a lipophilic 
central cavity and a hydrophilic outer surface. The most common CDs are α-, β- and γ-CDs, 
consisting of six, seven and eight α-D-glucopyranose units respectively (Cryan et al, 2004). 
The ability of CDs to improve drug bioavailability has been suggested to benefit from two 
features: (i) their membrane absorption enhancing properties and (ii) their ability to stabilise 
biomolecules in physiological media by shielding them from nonspecific interactions (Hao et 
al, 2012). The successful delivery of DNA to the livening cell requires a complex formation of 
DNA with its carrier (CD). The driving force behind the non-covalent formulation of DNA-
CD is the ability of CD to release water from the lipophilic cavity in favour of a more lipophilic 
entry. This causes a relaxation in the ring and decreasing the amount of strain felt by the cyclic 
system. All of this culminates in the complex becoming more stable.  
 
In gene delivery applications, cyclodextrins have favourable properties where they function as 
absorption enhancers in therapeutics transfer, and play a role in modulating the cytotoxicity of 
other polymers (Martin et al, 2007). Native CD has failed to form stable complex with DNA 
and hence has limited transfection efficiency. However derivative CD where they constructed 
by amendment of molecular parameter such as density and hydrophobic-hydrophilic balance 
has induced transfection rate (Ortiga –caballero et al, 2008). In vivo the interaction of 
cyclodextrin with specific host molecules can be improved by increasing its stability and 
solubility, using primary and secondary alcohol group reactions. These CDs derivatives have 
different property and hence will have different level of transfection and toxicity (Jianshu et 
al, 2010).  
 
Cyclodextrin has shown to be facile and effective approach in developing gene delivery when 
used as core system or alongside cationic lipid (Martin et al, 2013).  Incorporation of 
cyclodextrin with excipient such as folic acid and pluronic- F127 significantly affect the 
stability of DNA formulations and provide safe and effective DNA formulations (Eng et al, 
2014). The success of these formulations needs further investigations and transfection 
efficiency remains to be investigated. 
 
In non-viral gene formulations, stability plays a major role in developing this therapy to become 
a marketable product (Anchordoquy et al, 2001). The storage of gene formulations has been 
investigated with various DNA formulations including liquid, frozen and dehydrated 
formulations. Aggregation and short shelf life are the main limitations of liquid formulations 
(Anchordoquy et al, 2001). The frozen formulations are more successful compared to liquid 
formulations, but damage to DNA structure was reported as result of cryolysis (the formation 
crack within the ice).  Although the stability of frozen formulations was significantly improved 
by the addition of excipients, but difficult maintenance conditions were required. To overcome 
the limitation of liquid and frozen formulations, dehydrated formulations were developed. 
These formulations are stable at ambient temperature and can be ready to administer after a 
simple reconstitution step. The two main ways to remove water form liquid are spray drying 
and freeze-drying. Since spray drying could generate high shear forces and damage the gene 
vectors, freeze-drying become a preferable technique (Anchordoquy et al, 2001,).  
The future of gene therapy requires the advancement of non-toxic and effective gene delivery 
systems. Therefore, this study will be focusing on improving gene stability and transfection 
efficiency using carboxymethyl-β-cyclodextrin (CM-β –CD) as a novel non-viral vector 
(without any structural modification; which is different to many publications such as Diaz-
Moscoso et al 2009)  with a type of block co-polymer known as Pluronic- F127.  Pluronic –
F127 as pharmaceutical excipient has been proved to enhance the transgene expression as well 
as the therapeutic effect of the transgene via several delivery routes and various types of vectors 
including naked DNA itself (Kabanov et al, 2002). Moreover, in both vivo and vitro Pluronic- 
F127 has also showed significant ability to preserve the stability of polypeptide.  In this study, 
carboxymethyl-β-cyclodextrin will be used with and without Pluronic- F127 at different weight 
ratio to determine its effect on formulations stability. The stability of DNA formulations will 
be studied under fresh and freeze dried conditions.  The most successful formulation will be 
used to transfect, two different cell lines and the results will be compared to that of TransIT-
LT1 reagent (as a control). 
 
2. Materials and Methods 
  
 2.1 Materials 
Deoxyribonucleic acid (DNA) sodium salt from calf thymus was purchased from 
Sigma Aldrich (UK). TransIT-LT1 transfection reagent kit  was obtained from 
Mirus (UK). Purity of DNA was checked by monitoring the absorption spectrum and 
the ratio of the absorbance at 260–280 nm. The ratio being 1.87 indicated that the DNA 
was fully free from proteins. Deoxyribonuclease (DNase from bovine pancreas), 
carboxymethyl-β-cyclodextrin and Pluronic-F127 were also purchased from Sigma 
Aldrich (UK). High glucose Dulbecco’s modified Eagle’s medium (DMEM), 
primocine, Fetal bovine serum (FBS), L- Glutamine and trypsin were also purchased 
from sigma Aldrich (UK). 
 
 
2.2 Plasmid preparation 
In this study, plasmid expressing green fluorescent protein (pc DNA3.1-GFP) was amplified 
by transformation of E coli to produce a large quantity of the plasmid. Cells were plated into 
the ampicillin (200 g/ml) containing agar plates and stored at 370C overnight. A colony was 
picked from the plate and placed into 100mls of LB (Luria-Bertaini) medium and left for 
48hours on the shaker at 37oC. The DNA was extracted using a Maxiprep by following the 
manufacture protocol (Invitrogen, UK). Purity and quantity of the plasmid were checked using 
Nanodrop lite (thermo, UK). Purity was 1.9 (ratio of absorbance at 260nm/280nm) and quantity 
was 2μg/μl, this was also confirmed by taking UV measurement at 260nm and 280nm 
wavelengths.   
 
2.3 Cell line used 
 African green monkey fibroblast cells COS 7 and SH-SY5Y neuroblastoma cell lines 
were obtained from the University of Sunderland labs. The cell line was cultured in high 
glucose Dulbecco’s modified Eagle’s medium (DMEM) with o.5% primocine, 10% 
Fetal bovine serum (FBS) and 1% L- Glutamine. At 37oc and 5% CO2, cell were 
trypsinized and subcultured twice a week. 
 
2.4 Preparation of fresh and freeze-dried DNA samples 
The following preparations were made up in phosphate buffer saline (PBS) with 
pH 7.4 at various weight ratios of carboxymethyl-β-cyclodextrin(CM-β –CD) and pluronic-
F127 (see table 1 for all DNA and non-DNA solutions). DNA concentration was kept constant 
at 20 µg /ml, preparations were made up to 20mls using the PBS.  
 
Table 1: DNA samples made up to 20mls using PBS buffer 
Samples. 
DNA/EXCEPIANTS  
DNA (µg 
/ 
 CM-β –CD (µg/ Pluronic – Final DNA 
20ml) 20ml) 
F127(µg / Concentratio
n 20ml) (µg /ml) 
1    (1:0) 400 0 0 20 
2   (1:3) 400 1200 0 20 
3   (1:3:3) 400 1200 1200 20 
4   (0:3:3) 0 1200 1200 0 
5   (1:10) 400 4000 0 20 
6   (1:10:10) 400 4000 4000 20 
7   (0: 10:10) 0 4000 4000 0 
 
As drug delivery systems become more widespread, the challenge of their long-term 
stabilization will become of increasing importance (sameti et al, 2003). Freeze-drying is a 
well-established method used in the preservation of unstable pharmaceutical products over 
long periods of time, and has been shown to improve long term stability of DNA samples 
(Eng et al, 2014 and Martins et al, 2007). Non-viral vectors face two stages of stress during freeze 
drying process (freezing and drying), which has been reported to damage DNA especially during 
freezing process. However, these damages have not resulted in reduction of cell transfection (Allison 
and Anchordoquy 2000) and hence freeze drying method has been accepted for preparing dried 
formulations of proteins and non-viral gene vectors (Seville et al, 2002).    
The samples (see Table 1), were frozen at -80 
o
c for four hours, and then were taken to the 
freeze drier using Vir Tis benshtop k Freeze Drier (biopharma, UK). The condenser 
temperature was -105oC, the shelf temperature was 21 oC and the vacuum was set to 20mT. 
Solutions were left to dry for 48hrs and then characterised using Fluorescence, Fourier 
Transform Infra-red   Spectroscopy (FT-IR), gel elechtrophoresis, and DNase activity. For 
Fluorescence measurement, UV absorbance, gel electrophoresis and DNase activity, freeze 
dried samples were reconstituted by hydrating the powder back to solution using distilled 
water (dH2O). 
 
 
2.5 Characterization of fresh and reconstituted freeze dried DNA samples 
2.5.1  Fluorescence calibration curve for deoxyribonucleic acid (DNA) 
In order to measure the DNA fluorescence, Gel red was used to replace the highly toxic 
ethidium bromide. Gel red has been shown to be very safe and environmentally friendly. For 
fluorescence calibration curve, series of dilution were mad to contain, 0.5, 1, 2 and 2.5μg/ml 
from DNA stock solution of 20 μg/ml and 0.02% of Gel red. Samples were left for 30min to 
intercalate gel red with DNA. Fluorescence was then measured using the Perkin-Elmer 
Liminescence spectrophotometer (LS5OB, perkin-Elmer Ltd., UK) at λexcitation (592nm) 
and λemssion (592) characteristic to DNA (Cryan et al, 2004). 
 
 
 
2.5.2 Fluorescence measurements of DNA samples 
Fluorescence is type of luminescence created by electromagnetic excitation, which generated 
when a substance absorbed light energy at a short wavelength, and then emits light energy at a 
longer wavelength. Fluorescence test was done to measure the % of DNA incorporate inside 
cyclodextrin. It is generally agreed that strong fluorescence enhancement accompanied 
intercalation of the dye into the double helix is a conformation of DNA presence (Olmestedll 
et al, 1977). Adding the gel red to DNA samples, it intercalates between the base pairs of DNA 
double helix and fluorescence the available DNA that has not been incubated inside the 
cyclodextrin. This measurement, via the calibration curve, can determine the concentration of 
DNA in each sample. The fluorescence measurements of DNA samples were taken from fresh 
and freeze dried samples using the Perkin Elmer luminescence spectrophotometer, (LS5OB, 
Perkin-Elmer Ltd., UK). 10mls of 0.02% gel red was mixed with 10mls of each sample to give 
a final concentration of 1μg/ml. The non-DNA solutions were used as blank to eliminate any 
excipients interference  
 
2.5.3 DNase Activity measurements 
DNase is an enzyme that catalyzes the hydrolytic cleavage of phosphodiester linkage in the 
DNA backbone (Hedddi et al, 2010). Adding DNase to DNA solutions will determine 
whether DNA incorporated inside cyclodextrin cavity, any DNA that is not incorporated 
inside the cyclodextrin core will be available for DNase fragmentations and is an indication 
of unstable formulation. Fragmentation of DNA will lead to an increase of UV absorbance 
over time. One vial of DNase contain 0.93mg was diluted to 0.5ml with 0.15M NaCL. A 
volume of 0.1mls was further diluted to 1mls; 0.1ml was added to 3mls of each DNA 
containing samples and then absorbance measurement was taken at three different points 
0, 5 and 15 minutes, using the M501 Single beam Scanning UV/Visible Spectrophotometer 
(Campsec Biochrom). 
 
  2.5.4 Gel electrophoresis 
Gel electrophoresis is a method used to separate DNA, RNA and protein according to their 
sizes and charge (Hui-Qiao et al 2015). Interactions of DNA with excipients play a major role 
in gene therapy in order to protect DNA from any degradation. Agarose gel electrophoresis 
method was used to quantify the binding of DNA to cyclodextrin, any interaction between 
DNA and cyclodextrin will prevent DNA from traveling toward the positive charge. Agarose 
gels were prepared by dissolving 1g of agarose into 100ml of TAE buffer giving a gel 
concentration of 1%. 10µl of gel red was added to visualise the DNA when placed under UV 
light, then pour into electrophoresis apparatus. Two combs were used to make wells for 
fresh and freeze dried samples and left for 30min, then moved into gel box and cover with 
buffers, 8 µl of each sample was mixed with 5µl of loading dye and placed in each wall 
including DNA ladder. Solutions were left to run for one hour at 100V a n d  i m a g e d  
u s i n g  t h e  G e l  D o c  s y s t e m  (BioRad, UK). 
 
 
2.6 Characterization of freeze dried DNA powders USING Fourier Transform Infra-red Spectroscopy (FT-
IR) and Scanning Electron Microscopy (SEM) 
FT-IR spectroscopy is often used to characterize the nature of drug–DNA interactions and to 
monitor the effects of various drugs and excipients on DNA structure as well the binding sites 
of DNA (Ahmadi et al, 2010 and Hsiue, et al 1998). On this experiment FT-IR will determine 
any interaction between DNA and cyclodextrin. FT-IR was conducted on freeze dried DNA 
powders; using Perkin-Elmer FT-IR Series (Beakonsfield, Buckinghamshire, UK) FT-IR was 
conducted at a resolution of 4cm-1. 
SEM was used to study DNA–CD inclusion by monitoring any external morphology and 
chemical composition change.  Freeze dried samples were added to 15mm diameter 
aluminium stub using double-sided carbone adhesive tabs. All samples were coated with 
mixture of gold/palladium in high vacuum coating unit using Quarum Technology (polaron 
range SC760) by exposing samples to an argon atmosphere at about 10 Pascals. Samples 
were coated for 2x105 second with process current of 18-20 mA. After coating, samples were 
examined using Hitachi S3000N Scanning Electron Microscopy (Hitachi High Technologies 
UK-Electron Microscopes, Berkshire, UK).   
 
2.7 Preparation of transfection reagents 
The most stable DNA formulation was used for transfection. 24hrs before transfection 
0.6x105   Cos 7 cells and SH-SY5Y neuroblastoma cell line were plated in 6 well plates with 
2.5mls of DMEM, cells were ≥80 % confluence. TransIT-LT1 reagent were used as 
reference. 2μg DNA added to each formulation, CM-β –CD 1:3 and DNA: CM-β –CD: 
Pluronic-F127 1:3:3 and TransIT-LT1 and then mixed with 250μl of reduced –serum medium 
(Opti-MEM I). All formulations were mixed by pipetting gently and incubated for 30min at 
37oC. Each formulation added to 6 well plate and measurement was taken at 24, 48 and 72 
hours using the flow cytometry technique (BD Accuri, BD Biosciences, USA).  
 
2.8 Statistical analysis 
Univariate analysis of variance was performed for statistical analysis. Levene test was used 
to test the sample has equal variances. Equal variances cross samples is called homogeneity 
of variance. Tukey test was used as appropriate. The data are considered significant if the P 
value is less than 0.05. 
 
3. Results and Discussion 
 
The DNA condensation is prerequisite for successful gene delivery (Aviles et al, 2010). DNA 
undergoes a conformational transition from a semi-flexible coil to a more compacted state 
upon mixing with cyclodextrin, which has the ability to form polymers of nano-sized with 
DNA (Zerkoune et al, 2014). This formulation is attracted by electrostatic binding resulted 
from the phosphate group of the DNA backbone and the lipophilic inner cavity of the 
cyclodextrin (wang et al, 2002).  In this study, the ability of CM- β-CD polymer to condense 
DNA was evaluated by Agarose gel electrophoresis, fluorescence, FT-IR, DNase activity and 
transfection  
 
3.1 Fluorescence measurements for fresh and freeze dried DNA samples  
For fluorescence intensity measurements for fresh DNA samples, the results were applied to 
the equation of line of regression from the DNA fluorescence calibration curve (see 
Equation 1) to determine the DNA concentration.  
 
        y= 33.5-7.1                 Equation 1 
  
 
The % of DNA inclusion into cyclodextrin cavity was calculated using Equation 2. Decrease 
in fluorescence intensity would results in higher % inclusion due to the unavailability of 
DNA to gel red dye. 
 
% Of inclusion = (theoretical DNA concentration- concentration of DNA measured by Fluorescence)  x 100 
                                                                                   Theoretical DNA concentration (1g/ml) 
Equation 2 
 
 Results from Table 2 demonstrated that DNA : CM-β –CD 1:3 and DNA 1:10 were the most 
stable formulations with highest % of DNA inclusion 20.51% and 20.3% respectively. 
Followed by samples DNA: CM-β –CD:Pluronic F127 1:3:3 with 16.44% while sample DNA: 
CM-β –CD:Pluronic F127 had only 14.9% inclusion.  Unianova, analysis of variance was done 
to determine whether the samples differed significantly (p<0.05). It was found that the most 
stable freshly prepared aqueous formulations CM-β-CD:DNA 1:3 and 1:10 differed 
significantly (p<0.05) from DNA : CM-β –CD:Pluronic F127 1:3:3 and 1:10:10. 
 
 
Table 2 shows % of inclusion of DNA (as average and S.D.) inside cyclodextrin from fresh 
and freeze dried DNA samples 
Samples  Average 
for fresh 
samples 
SD Average 
for 
freeze 
dried 
samples 
SD 
DNA: CM-β –CD 
1:3 
 
20.51% 0.08 
 
44.20% 0.01 
 
DNA: CM-β –CD:Pluronic 
F127 
1:3:3 
16.44% 0.09 
 
33.70% 0.08 
 
DNA: CM-β –CD 
1:10 
 
20.32% 0.07 
 
45.87% 0.02 
 
DNA: CM-β –CD:Pluronic 
F127 
1:10:10 
14.93% 0.04 
 
25.87% 0.01 
 
 
The results for DNA concentration and % DNA inclusion for freeze dried samples are 
illustrated in Table 2. Formulations DNA: CM-β –CD 1:3 and 1:10 had the highest % of 
inclusion and were the most stable formulations compared to other freeze dried samples. 
Based on the statistical analysis (Unianova,), both these formulations were significantly 
differred (p<0.05) from the least stable formulations (DNA:CD:Pluronic F127 (1:10:10) and 
the rest of freeze dried formulations.  
 
Fresh and freeze dried DNA formulations were made to contain 1μg/mL of DNA. The decrease 
in fluorescence intensity in most samples indicates some degree of DNA inclusion into the 
cyclodextrin complex. In comparison, freeze dried formulations to fresh formulations, freeze 
dried samples provided higher % of DNA inclusion inside cyclodextrin cavity. Where nearly 
double the % of DNA inclusion was reported for freeze dried samples (Table 2) compared to 
fresh DNA aqueous solutions (Table 2).   
The stability of DNA- CM-β –CD complex was also investigated in the presence of Pluronic 
F-127 for both fresh and freeze-dried formulations. Although the addition of Pluronic F-127 
as stabilising excipients to the samples was expected to enhance the stability of formulations, 
results show no significant (P > 0.05) effect of Pluronic F-127 on the samples. Moreover, a 
slight decrease in the % of DNA inclusion was noticed in some DNA-CD formulations.  The 
decrease in DNA inclusion into cyclodextrin in the presence of Pluronic F-127 might be 
related to the formation of micelles. Pluronic F127 is an amphiphilic molecule, which forms 
spherical micelles with hydrophobic cores and hydrophilic coronas, above critical micelles 
concentration (CMC) in aqueous solution forms (Rajib et al 2013).  
Fluorometry is a very sensitive method used to measure the concentration of DNA and it is 
known to be more accurate than absorbance at 260nm (Rengajaran et al, 2002). This method 
is highly specific in terms of differentiating double stranded DNA from single stranded or 
RNA, and able to detect a small amount of double stranded DNA. Ethidium bromide 
fluorophore is a preferable stain that usually used in this method. However due to health and 
safety issues it was replaced with Gel-red which is widely used stain in molecular biology 
that also known to be sensitive, safe and an easy stain for DNA.  
 
 
3.2 DNase I activity measurements 
  
The stability and DNA incorporation for fresh and freeze dried DNA formulations were 
investigated using DNase enzymes activity measurements. The degree of DNA formulation 
stability is obtained from the difference between the absorbance readings from time 0 to 15 
minutes, the smaller the difference in absorbance the higher the stability.  
For DNase I activity measurements for fresh DNA samples, the results of DNase I activity 
measurements at time 0, 5 and 15 minutes for fresh DNA aqueous samples are illustrated in 
Table 3.  
 
 
 
 
 
 
 
 
 
 
Table 3: DNase I activity measurements against fresh and freeze 
dried DNA samples 
Fresh  
Samples 
Absorbance 
At ta=0 
Absorbance 
At ta=5 
Absorbance 
At ta=15 
Change in 
absorbance  
At ta=15 
DNA  0.412 0.419 0.421 0.009 
DNA- CM-β –
CD 
1:3 
0.440 0.442 0.443 0.003 
DNA- CM-β –
CD - 
pluronic 
1:3:3 
0.356 0.359 0.361 0.005 
DNA- CM-β –
CD 
1:10 
0.347 0.352 0.359 0.011 
DNA- CM-β –
CD -Pluronic 
1:10:10 
0.309 0.309 0.319 0.010 
Freeze Dried 
Samples 
 
Absorbance 
At ta=0 
Absorbance 
At ta=5 
Absorbance At ta=15 Change in 
absorbance 
At ta=15 
DNA alone 0.327 0.331 0.344 0.017 
DNA-CD 1:3 0.125 0.126 0.126 0.001 
DNA-CD- 
pluronic 1:3:3 
0.171 0.172 0.175 0.004 
DNA-CD 1:10 0.279 0.290 0.293 0.014 
DNA-CD-
Pluronic  
1:10:10 
0.268 0.280 0.281 0.013 
 
 
Results of DNase I activity measurements for fresh DNA samples revealed that formulations 
with DNA: CM-β –CD:Pluronic-F127 1:3:3 and 1:3 DNA: CM-β –CD had the smallest change 
in absorbance. Thus, these formulations are the most stable DNA formulations indicating high 
incorporation of DNA within the CM-β –CD. Samples DNA: CM-β –CD 1:10 and DNA : CM-
β –CD:Pluronic F 127 1:10:10 showed less DNA protection against DNase I degradation.  
 
 
For DNase I activity measurements for freeze dried DNA samples, Table 3 shows the results 
of DNase I activity measurements at time 0, 5 and 15 minutes for freeze dried DNA samples.  
Based on the results, the most stable freeze dried formulations that provide most protection 
from DNase I degradation were DNA: CM-β –CD 1:3 and DNA: CM-β –CD:Pluronic F127 
1:3:3. While samples DNA-CD 1:10 and DNA:CM-β –CD:Pluronic F127  1:10:10 showed 
higher change and less stability (p < 0.05).  
The results of DNase I activity from both freeze dried and fresh formulations have revealed 
that low concentration of CM-β–CD provided better protection for DNA than higher 
concentration. The effectiveness of CD at low concentration was also noticed in the 
fluorescence measurements (see Table 2) where samples with low CM-β–CD concentration 
showed high % of DNA inclusion with no benefit from the increase of CM-β–CD 
concentration. Results suggested that CM-β–CD provide protection for DNA at low 
concentration with and without the presence of Pluronic F127. The increase in formulations 
stability at low CM-β–CD concentration was also confirmed by gel electrophoresis (see 
below).  
The decrease in formulations stability at high level of CM-β–CD may be due to the formation 
of favourable bonds or interaction between the CM-β–CD molecules at the hydrophilic site 
leaving DNA with little or no site to bind to (Allison et al, 2000).          
 
3.3 Gel electrophoresis 
The phosphate molecules that make up the backbone of DNA molecules have a high 
negative charge. When DNA is placed on a field with an electric current, these negatively 
charged DNA molecules migrate toward the positive end of the field creating DNA bands. 
Formulations that have high stability and good DNA inclusion inside cyclodextrin will 
show little or no bands of DNA.  
Gel elcectrophoresis for fresh DNA samples    
Figures 1 and 2 show the results of gel electrophoresis of fresh DNA aqueous samples and 
freeze dried  DNA samples, respectively.  
 
 
 
 
 
 
 
 
Figure 1: Agarose gel electrophoresis for β-CD-cm:DNA:Pluronic-F127 samples from fresh 
samples. Lane 1: DNA ladder; lane 2: pure DNA; lane 3: DNA:CD 1:3 lane 4: 
DNA:CD:Pluronic 1:3:3; Lane 5: CD:PLURONIC 3:3; lane 6: DNA:CD 1:10; lane 7: 
DNA:CD:Pluronic 1:10:10; lane 8: CD:Pluronic 10:10. 
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Figure 2: Agarose gel electrophoresis for β-CD:DNA:PluronicCF127 samples from freeze 
dry samples. Lane 1: DNA ladder; lane 2: pure DNA; lane 3: DNA:CD 1:3 lane 4: 
DNA:CD:Pluronic 1:3:3; Lane 5: CD:PLURONIC 3:3; lane 6: DNA:CD 1:10; lane 7: 
DNA:CD:Pluronic 1:10:10; lane 8: CD:Pluronic 10:1 
 
 
 
 
 
Results from gel electrophoresis for fresh DNA samples showed no movement of DNA for lane 
3 ( DNA: CM-β –CD  1:3) and line  4  ( DNA: CM-β –CD:Pluronic F127  1:3:3) (see Figure 1). 
Similar results were also obtained from freeze-dried samples. Samples 3 and 4 (1:3 DNA: CM-
β –CD and 1:3:3 DNA: CM-β –CD:Pluronic F127) show no DNA fragment (see Figure 2) 
suggesting good condensation of DNA inside cyclodextrin cavity.  
These results have confirmed that DNA with low CM-β –CD concentration has formed more 
stable complex than DNA with higher CM-β –CD concentration, which support the results from 
Fluorescence and DNase activity measurements as explained above. 
 
 
3.4 Fourier Transform Infra-red Spectroscopy (FT-IR) 
 
FT-IR was used to indicate any interaction between DNA and cyclodextrin for dried 
samples.  Interaction between CM-β –CD: DNA will result in shifting DNA peaks. FT-IR will 
give structure information of the entire molecule and any conformational change to DNA 
biomolecules.  Since FT-IR is a fast method and only required small amount of sample, it 
becomes ideal for the study of DNA (Deepak et al 2010).  Results of FT-IR showed that 
cyclodextrin binds to DNA through direct interaction with DNA bases (guanine, thymine, 
adenine and cytosine), with a small perturbation of phosphate group of DNA backbone. It 
could be inferred that this interactive model of CM-β –CD with DNA is an electrostatic 
binding (Wang et al 2002, Zhao et al 1999). The measurements were taken at 1800-
650 cm−1 spectral range with a resolution of 4 cm−1. Background spectra were collected 
and subtracted before each measurement. Four main peaks have been identified in pure 
freeze dried of DNA as shown in Figure 3: 1155.36 cm-1 (the sugar-phosphate band of the 
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C—O of the ribose-phosphate bond), 1074.35 cm-1  (arise from the antisymmetric and 
symmetric vibrations of the PO2
− groups ), 954.76 cm-1   (arise from C–C and C–O 
vibrations in deoxyribose ) and 858.32cm-1    (reflect the phosphate-sugar backbone ).  The 
present results were expected and have been reported by other studies (Eng et al, 2014 
and Mao et al, 1993). Cyclodextrin molecule has peaks at 858.43 cm-1, 956.69 cm-1, 
1066.64 cm-1, 1153.43 cm-1.  It is clear that, 954.76cm-1    peak from DNA and 1066 cm-1 
and 956.69 cm-1 from cyclodextrin no longer present on samples of 1:3 DNA:CM-β- CD 
and 1:3:3 DNA: CM-β- CD:Pluronic F-127 (data not shown). However, there is new peak 
appeared at 947.05cm-1 that could be as results of two peaks overlapped and created 
broader peak, i ndicating an interaction of DNA with CM-β –CD. 
The inclusion of DNA with CM-β- CD and pluronic F-127 at low concentration 1:3 and 
1:3:3 showed similar results to higher concentration 1:10 and 1:10:10. This inclusion 
has supported our result from DNase activity and Florescence. The peak at 954.76cm-1 
was shifted to 945.12cm-1 (see Figure 3); this could be explained by t h a t  the sugar 
molecules of cyclodextrin binding together at higher concentration leaving no site for 
DNA binding. 
 
 
 
 
Figure 3: FT-IR graphs for DNA alone (red line), DNA :CD 1:10( green line ) and  DNA 
:CD:PL  (1:10:10 ) (black line) 
 
3.5 Scanning Electron Microscopy (SEM) 
 
SEM was used to give information about the sample including external morphology 
(texture), crystalline structure and orientation of materials making up the sample. Figure 4 
shows the SEM image at the same magnification of 10000x. There are changes in the 
external morphology and shape that can be seen in all formulations with CM-β –CD 
compared to the morphology of DNA alone. This is an indication that DNA has interacted 
within CM-β –CD formulations. 
 
 
DNA 
 
DNA: CM-β –CD 1:3 
 
DNA: CM-β –CD: Pluronic 
1:10:10 
Figure 4: SEM photomicrographs for DNA and DNA: CM-β –CD formulations  
 
 
3.6 Transfection 
 
The physiochemical property of CM- β –CD and its ability to form complexes of nano-sized 
with DNA has shown to be the first step to transfection. Before transfection the ability of CM-
β-CD to condense DNA was confirmed by gel electrophoresis where CM- β –CD has the ability 
to condense DNA at weight ratio of 1:3. The enhancement of gene transfection, when 
liposomes were incorporated with less polar cyclodextrin, could be as result of non-specific 
interaction with cell membrane ingestion by endocytosis rather than an electrostatic interaction 
(Kannan et al 2004). Figures 5 and 6 reveal the data for gene transfection containing CM-β-
CD. 
 
Following the transfection of COS 7 cell line with both LT1 and CM-β –CD for 48hrs the 
expression of GFP is showing in Figure 5, the highest level of expression was detected after 
48hrs of transfection with CM-β –CD this has shown that transfection with CM-β –CD 
containing pDNA gave similar or even better results compared to LT1 containing pDNA. 
 
SH-SY5Y neuroblastoma cell is showing to be harder to transfect than COS 7. However, 
pDNA:CM-β –CD still showing 20.4% transfection (Panel 2) which is higher than LT1 (as a 
reference) with transfection of 18.2% (Panel 4). CM-β –CD and LT1 both were used to 
transfect different type of cells COS 7 and SH-SY5Y. CM-β –CD has the ability to form 
complex with pDNA and it shows higher transfection rate than LT1. Different transfection 
rate was recorded for different cell lines and higher transfection rate for pDNA:CM-β –CD 
was persistently confirmed.            
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Panel 1      Panel 2 
 
Panel 3      Panel 4 
 
Panel 5      Panel 6 
 
Figure 5 shows FCS results of COS 7 when transfected with LT1 (a reference in the form of 
commercial liposomes) after 48hrs or pDNA:CM-β –CD. LT1 has resulted in 51.7% 
transfection efficiency (Panel 2) when comparing with pDNA:CM-β –CD (1:3) which 
resulted on 59.3% transfections (Panel 4). Panels 5 and 6 are for excipients (CM-β-CD and 
Pluronic F-127). 
 
 
 
 
Panel 1      Panel 2 
 
 
Panel 3      Panel 4 
 
 
Panel 5      Panel 6 
 
Figure 6 shows FCS results of SH-SY5Y neuroblastoma cell when transfected with LT1 (a 
reference in the form of commercial liposomes) after 48hrs or pDNA:CM-β –CD. 
pDNA:CM-β –CD (1:3) resulted in 20.4% transfections (Panel 2) compared to 18.2% 
transfection efficiency (Panel 4) from pDNA/LT1. Panels 5 and 6 are for excipients (CM-β-
CD and Pluronic F-127). 
 
 
  
4. Conclusion 
 
All formulations DNA: CM-β-CD (1:3), DNA- CM-β-CD (1-10), DNA: CM-β:CD: Pluronic–
F127 (1:3:3) and DNA:CD:PL F-127 (1:10:10) have shown to provide protection against 
DNase degradation. Formulations with lower CM-β-CD and Pluronic F-127 provided more 
protection than the DNA: CM-β-CD: Pluronic–F127 at high ratio. After freeze-dried all 
formulations increased their protection to DNA from DNase degradation. DNase results were 
also supported by gel electrophoresis, where formulations with low DNA: CM-β-CD ratio has 
provided better inclusion between DNA and CM-β-CD. The Fluorescence measurement for 
fresh formulations showed the % of inclusion for both DNA:CM- β -CM CD (1:3) and (1:10) 
20% and hence there was no benefit from increasing cyclodextrin concentration. The addition 
of Pluronic F-127 to both formulations resulted in small reduction in the % of inclusion.  Freeze 
dried formulations significantly increase the % of inclusion for both DNA-CM-β –CD (1:3) 
and DNA- CM-β –CD (1:10) to 44% and 45% respectively. The FT-IR showed that all 
formulations have resulted in some level of interaction (broadening and shifting of the peaks). 
The change only occurs at peak 954 cm-1. This peak is a result of the (PO4
3−) group in the sugar-
phosphate backbone of DNA. This is a confirmation that CM-β-CD may interact with the 
anionic group (PO4
3−) in the sugar-phosphate backbone of DNA and hence this was observed 
in DNA: CM-β –CD (1:3), DNA: CM-β –CD (1:10) and DNA- CM-β –CD: Pluronic–F127 
(1:3:3; 1:10:10), which also confirms that only small part of DNA was bind with the 
cyclodextrin. Freeze dried formulations have shown to be more stable than freshly prepared 
formulations, this could be as a result of the advantage of converting solutions into solid forms 
which will prevent the particles from aggregation and degradation. The increase of inclusion 
after freeze-drying could be a result of favourable bond been formed. These bonds are most 
likely to be non-covalent in nature such as electrostatic interaction, hydrophobic, hydrogen 
bonds and Van der Waals, which has also been confirmed by FT-IR data. In conclusion, it was 
found that cyclodextrin at ratio of DNA: CM-β –CD 1:3   provide a good protection for DNA, 
with and without Pluronic F-127 and no advantage in increasing cyclodextrin concentration. 
Transfecting COS 7 and SH-SY5Y neuroblastoma cell lines using CM-β-CD has not just 
shown to be able to transfect both cell line it also revealed higher transfection efficiency 
compare to TransIT-LT1 reagent. Results have also confirmed that the addition of Pluronic–
F127 resulted in low or no transfection. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 References 
Ahmadi, F. and Bakhshandeh, F., 2009. In vitro study of damaging effects of 2, 4-
dichlorophenoxyacetic acid on DNA structure by spectroscopic and voltammetric techniques. DNA 
and cell biology, 28(10), pp.527-533. 
 
Ahmadi, F., Alizadeh, A.A., Bakhshandeh-Saraskanrood, F., Jafari, B. and Khodadadian, M., 2010. 
Experimental and computational approach to the rational monitoring of hydrogen-bonding 
interaction of 2-Imidazolidinethione with DNA and guanine. Food and chemical toxicology, 48(1), 
pp.29-36. 
 
Akinori, K. Toshiyuki, O. Tsugutoshi, W. suguru, N. Jun, S., Toshihiro, I. Akinori, J. and 
Komiyama, M. (2009) ‘ Efficient Guest Inclusion by β-Cyclodextrin Attached to the Ends of DNA 
Oligomers upon Hybridization to Various DNA Conjugates’. The University of Tokyo. 
Bioconjugate Chem.  20 (8), pp. 1643–1649. 
 
 
Alexander, R.R., and Griffiths, J.M. (1993) Basic Biochemical Methods, 2nd Edition. J.M. 
Wiley and Sons, New York. 
 
Allison SD and Anchordoquy TJ, (2000) Mechanism of protection of cationic lipid- DNA 
complexes during lyophilisation process :the practical isolation hypothesis. Biochem. BioPhys. 
Acta . 1468: pp127-138. 
 
 
Anchordoquy, J T. Allison, S D.  Moliana, M D. Girouard, L G. Carson, T K. (2001) ‘physical 
syabilization of DNA based therapeutic’ Drug discovery, (6), pp. 463-470. 
 
Avilés, M.O., Lin, C.H., Zelivyanskaya, M., Graham, J.G., Boehler, R.M., Messersmith, P.B. and 
Shea, L.D., 2010. The contribution of plasmid design and release to in vivo gene expression 
following delivery from cationic polymer modified scaffolds. Biomaterials, 31(6), pp.1140-1147. 
 
 
Bing, L. Jun, J, D. Fang, Y. Ning, Y. Wei, L. Jian, R, Y. Shu, X, P. Long, C, X. Cong, G. Li M, 
Zhang. ‘Efficient gene transfection in the neurotypic cells by starHshaped polymer consisting of 
βHcyclodextrin core and poly(amidoamine) dendron arms’,Article Carbohydrate Polymers,  94 
(1), pp.185-192. 
 
Croyle, M,A. Roessler, B J.  Hsu. B J, Sun G,L. (1998).’ Amidonβ cyclodextrins enhance 
adenoviral mediated gene delivery to the intestine’ , Pharm. (15) pp. 1348– 1355. 
 
Cryan, S.A. Holohan, A. Donohue, R. Darcy, R. O'Driscoll, C.M. (2004) ‘Cell transfection with 
polycationic cyclodextrin vectors’.  European Journal of Pharmaceutical  Science, 21 pp. 625–633. 
 
Davis, M.E. and Brewster, M.E., 2004. Cyclodextrin-based pharmaceutics: past, present and future. 
Nature Reviews Drug Discovery, 3(12), pp.1023-1035. 
 
Deepak,  K.  Gunjan, Tyagi. Ranjk, ana Mehrotra, Suman, Kundu. ( 2010) ‘Carboplatin interaction 
with calf-thymus DNA: A FT-IR spectroscopic approach’ Journal of Molecular Structure, Volume 
969, Issues 1-3. 
 
Diaz-Moscoso, A. Le Gourrierec, L. Gomez-Garcia, M. Benito, J.M. Balbuena, P. Ortega-Caballero, 
F. (2009).’ Polycationic amphiphilic cyclodextrins for gene delivery: synthesis and effect of 
structural modifications on plasmid DNA complex stability, cytotoxicity, and gene expression’. 
Chemistry, 15 pp. 12871–12888 
 
Eng, M., A Elkordy, A., A McCarron, P., A Elkordy, E. and Faheem, A., 2014. Physical 
Characterisation as an Insight into a Gene Delivery System Containing Cyclodextrins with 
PluronicÆ-F127 and Folic acid as Non-Viral Vectors. Current pharmaceutical biotechnology, 15(8), 
pp.712-726. 
 
Gudnason, H. Dufva, M. (2007).’ Comparison of multiple DNA dyes for real-time PCR: effects of 
dye concentration and sequence composition on DNA amplification and melting temperature’, 
Nucleic Acids Research.  35(19): e127.  
 
Ghorab, M. K. and Adeyeye, M. C.  (2001). ‘ Enhancement of ibuprofen dissolution via wet 
granulation with beta-cyclodextrin’. Pharm Dev Technol. 6 (3), PP. 305-314.  
 
Halama, A. Kulinski, M. Librowski, T. Lochynski, S. ( 2009). ‘PolymerH based nonHviral gene 
delivery as a concept for the treatment of cancer’, Pharmacology, (61), pp.993C 999. 
 
HAO, X.H., SUN, M., DENG, J., SHI, C.P. and LI, H.M., 2012. Slow-Released Antibacterial 
Properties of Clove Essential Oil Inclusion Complex. Food Science, 11, p.019. 
 
 
Hinrichs, W.L.J., Mancenido, F.A., Sanders, N.N., Braeckmans, K., De Smedt, S.C., Demeester, J. 
and Frijlink, H.W., 2006. The choice of a suitable oligosaccharide to prevent aggregation of 
PEGylated nanoparticles during freeze thawing and freeze drying. International journal of 
pharmaceutics, 311(1), pp.237-244. 
 
 
Hedddi, B. Abi-Ghanem, J. Lavigne, M. Hartmann, B. (2010).   ‘Sequence-Dependent DNA 
Flexibility Mediates DNase I cleavage’,  Journal of Molecular Biology. Volume 395, Issue 1, 
PP. 123-133. 
 
Hill, C.L., Bieniasz, P.D. and McClure, M.O., 1999. Properties of human foamy virus relevant to its 
development as a vector for gene therapy. Journal of General Virology, 80(8), pp.2003-2009 
 
Howden, S.E., Voullaire, L., Wardan, H., Williamson, R. and Vadolas, J., 2008. Site-specific, Rep-
mediated integration of the intact β-globin locus in the human erythroleukaemic cell line K562. 
Gene therapy, 15(20), pp.1372-1383. 
 
Hoag, H (2005). ‘gene therapy rising’  Nature,  435 (3) pp.530-531 
 
Hsiue, G.-H. Liao, C.-M. Lin, S.-Y. (1998).  ‘Effect of Drug-Polymer Interaction on the Release 
Characteristics of Methacrylic Acid Copolymer Microcapsules Containing Theophylline’,  Artif 
Organs 22 (8), PP. 651-656.  
 
 
Hui-Qiao, Wang. Zhao-Xiang, Deng. (2015). ‘Gel electrophoresis as a nanoseparation tool serving 
DNA nanotechnology’.  Chinese Chemical Letters.  
 
 
Inchul Yang, Myung-Sub Han, Yong-Hyeon Yim, Euijin Hwang, Sang-Ryoul Park.  (2004).’ 
Measurement of UV absorbance is commonly used for quantification of DNA. The result of UV 
absorbance is described generally in the unit of optical density (OD) of which definition is 
absorbance of UV light through 1 cm absorption path length’. Analytical Biochemistry. Volume 
335, issue1, pp 150-161 
 
Jianshu, L. Zhizhang, G. Jianyu, x. Guanglei, Z. Huining, o. (2010) .21- arm star polymers with 
different cationic groups on cyclodextrin core for DNA delivery. Carbohydrate Polymers, Vol 
(79), Issue 2, pp. 277-283.  
 
 
Kabanov, A.V., Batrakova, E.V. and Alakhov, V.Y., 2002. Pluronic® block copolymers as novel 
polymer therapeutics for drug and gene delivery. Journal of controlled release, 82(2), pp.189-212. 
 
Kannan, S., Kolhe, P., Raykova, V., Glibatec, M., Kannan, R.M., Lieh-Lai, M. and Bassett, D., 
2004. Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial 
carcinoma cells. Journal of Biomaterials Science, Polymer Edition, 15(3), pp.311-330. 
 
Kun, S. Rongqin, H. Jianfeng, L. Liang, H. Liya, Y. Jinning, L. Chen, J. (2010). AngiopepC 2 
modified PECPEG based polymeric miceles for amphotericin B delivery targeted to the brain. 
Journal of Controlled Release (147), Issue 1, pp. 118-126. 
 
Lawrencia, C., Mahendran, R. and Esuvaranathan, K., 2001. Transfection of urothelial cells using 
methyl-ß-cyclodextrin solubilized cholesterol and Dotap. Gene therapy, 8, pp.760-768. 
 
Liu, F. and Huang, L., 2002. Development of non-viral vectors for systemic gene delivery. Journal 
of controlled release, 78(1), pp.259-266. 
 
Mao, U. Daniel, L.N. Whittaker, N. Saffiottil, U.  (1993). ‘DNA binding to crystalline silica 
charactarised by fourier-transform infrared spectroscopy’. Environ health prospect.  
 
Martins, CF. Bao, SN. Dode ,MN.  Correa, GA.  Rumpf , R.(2013). ‘Effects of freeze dry on 
cytology, ultrastructure, DNA fragmentation and fertilizing ability of bovine sperm’.  
Therioqenology 67 (8): 1307-15. 
 
Mulligan, R.C., 1993. The basic science of gene therapy. Science, 260(5110), pp.926-932. 
 
 
Nazarenko, I.  Pires, R. (2002) ‘Effect of primary and secondary structure of 
oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes’. Nucleic Acids 
Research, 30(9): pp. 20892195. 
 
 
Ortiga –caballero,  F.  Mellet CO L. Gourrierec, L. Guilloteau  N. Di Giorgio, C. Vierling, P.(2008) 
Tailoring  β-cyclodextrin for DNA complexation and  delivery  by homogeneous functionalization at 
secondary face . organic lett  vol 10.  5143-5146. 
 
Rajib, B. and Ranjini, B. (2013). ‘Encapsulation of Hydrophobic Drugs in Pluronic F127 Micelles: 
Effects of Drug Hydrophobicity, Solution Temperature, and pH’. Langmuir 29 (13), pp 4350–4356. 
 
 
Sameti, M., Bohr, G., Kumar, M.R., Kneuer, C., Bakowsky, U., Nacken, M., Schmidt, H. and Lehr, 
C.M., 2003. Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene 
delivery. International journal of pharmaceutics, 266(1), pp.51-60. 
 
Seidel CAM, Schulz A, and Sauer MHM. (1996) ‘Nucleobase-Specific Quenching of Fluorescent 
Dyes. 1. Nucleobase One-Electron Redox Potentials and Their Correlation with Statistic and 
Dynamic Quenching Efficiencies’. Journal of Physics and Chemistry’. 100:pp.  55415553.  
 
 
Seville, P.C., Kellaway, I.W. and Birchall, J.C., 2002. Preparation of dry powder dispersions for 
non‐viral gene delivery by freeze‐drying and spray‐drying. The journal of gene medicine, 4(4), 
pp.428-437. 
 
Silva, M L. Coelho, N. L. Malachias, A. Perez, C.A. Pesquero, J.L. Magalhaes Paniago, R. (2011) 
‘Study of the structural organization of cyclodextrin–DNA complex loaded anionic and pH-
sensitive liposomes’. Chemical physics letters. Volume 506, Issues 13. pp.66-70 
 
 
Wang, X. Pan, J. Yang, X. Niu, C. Zhang, Y. Shuang, S. Porphyrin. (2002)’ binding to DNA 
investigated by cyclodextrin supramolecular system’. Chemistry Department of Shanxi 
University.  Volume 374, Issue 3, pp. 445-450. 
 
Wang, X., Luo, Z. and Xiao, Z., 2014. Preparation, characterization, and thermal stability of β-
cyclodextrin/soybean lecithin inclusion complex. Carbohydrate polymers, 101, pp.1027-1032. 
 
 
 
Zerkoune, L. Angelova, L. Zerkoune, S.  (2014). ‘Nano-Assemblies of Modified Cyclodextrins 
and their Complexes with Guest Molecules:incorporation in nanostructured membranes and 
amphilphile nanoarchitectonics Design.  
 
Zhen-Zhen, L. Wu,  J. Sun , TM. Ji,  j. Yan, LF. Wang, J. (2008). ‘Biodegradable Polycation 
and plasmid DNA multilsyer Film for prolonged gene delivery to mouse osteoblasts’. 
Biomaterials 29: pp733-741. 
 
 
Zhao, G.C., Zhu, J.J. and Chen, H.Y., 1999. Spectroscopic studies of the interactive model of 
methylene blue with DNA by means of β-cyclodextrin. Spectrochimica Acta Part A: Molecular and 
Biomolecular Spectroscopy, 55(5), pp.1109-1117. 
 
 
 
 
 
 
 
